Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Biomaterials combined with stem cells show promise for improving tissue repair and medical treatments.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Nanoparticles improve cancer treatment by reducing side effects and targeting cancer cells better.

c-Kit is important for heart regeneration and cancer development.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Personalized treatment plans combining natural and synthetic approaches are important for managing alopecia effectively.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

The combination therapy was effective and well-tolerated, especially in young patients.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Some minoxidil combinations can help differentiate leukemia cells without harming other cells.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

Methotrexate effectively controls eye inflammation in Japanese patients with non-infectious uveitis but requires careful monitoring for side effects.

Acitretin improved monilethrix symptoms temporarily, but they returned after stopping treatment.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.